Skip to Content Facebook Feature Image

DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam

Business

DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
Business

Business

DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam

2024-11-08 20:11 Last Updated At:20:35

HANOI, Vietnam, Nov. 8, 2024 /PRNewswire/ -- DND International Eye Hospital is the first facility in Vietnam to implement SMILE Pro technology, an advanced FDA-approved eye refractive surgery method. It is also an ideal destination for international tourists seeking to combine travel with refractive eye surgery.

Health tourism is rapidly gaining popularity in Asia, and Eye Refractive Surgery in Vietnam is becoming an appealing option for international tourists due to its high-quality medical services and affordability.

Travelers are increasingly seeking not just attractive destinations but also opportunities to improve their health, particularly through medical services like eye refractive surgery. Vietnam is emerging as a prime destination that fulfills both tourism and healthcare needs, with the DND International Eye Hospital in Hanoi being a leading choice for eye refractive surgery.

1. Convenient Solution: Combining Tourism and Eye Refractive Surgery

Many international travelers are opting to combine tourism with myopia surgery to save time and costs. The surgery is safe, quick, and offers a short recovery period, making it ideal during travel.

At DND International Eye Hospital, a pre-surgery eye examination takes about two hours, and the surgery itself lasts only 15-20 minutes. Patients can even complete a comprehensive exam and surgery in a single day. After a 24-hour post-surgery check, they can continue exploring Vietnam's beautiful sights with confidence.

2. Cutting-Edge Technology for Eye Refractive Surgery

Quality equipment and technology are crucial when choosing a place for  lasik surgery. DND International Eye Hospital is equipped with state-of-the-art systems that meet international standards. This includes advanced diagnostic tools and the latest laser machines, such as the VISUMAX 800 laser with SMILE Pro technology and the Femto LDV Z8 from Ziemer, both of which are FDA-certified for safety and effectiveness.

SMILE Pro's 2mm incision quickly corrects refractive errors while minimizing risks and promoting fast recovery. DND leads the Asia-Pacific region in the number of SMILE surgeries, demonstrating its credibility and service quality.

3. Leading Ophthalmologists in Vietnam

DND International Eye Hospital features a highly qualified team of ophthalmologists with over 30 years of experience. These specialists are pioneers in SMILE technology and continually update their skills at international institutions, ensuring that each surgery is performed by experts dedicated to the latest medical advancements.

Additionally, the doctors and staff are proficient in English, facilitating effective communication with international patients. This presence of top specialists and English-speaking personnel builds trust among local and international patients alike. The hospital also offers 24/7 support for patients before and after surgery.

4. Cost-Effective Lasik Eye Surgery

Myopia surgery in Vietnam is attracting international tourists due to its affordability. Compared to countries like the U.S. and Japan, the costs in Vietnam are significantly lower while maintaining comparable quality. For instance, while SMILE surgery costs around $6,000 - $8,000 in the U.S., in Vietnam, it is only about a third of that price.

5. Comprehensive Examination Process for Safety

DND International Eye Hospital prioritizes patient safety with a thorough examination process comprising eight international standard steps. This includes various assessments to ensure safe surgery and optimal outcomes tailored to individual needs.

6. 5-Star Medical Service

DND International Eye Hospital offers a 5-star service experience, featuring a friendly environment and attentive care. Patients are warmly welcomed and guided throughout their treatment, and the hospital provides free periodic post-surgery checkups to ensure ongoing health monitoring.

The health tourism trend, especially in eye refractive surgery, presents numerous opportunities for international visitors to Vietnam. With modern technology, a specialized medical team, and attentive service, DND International Eye Hospital is the perfect choice for those looking to enhance their vision while enjoying a memorable vacation. The hospital guarantees a remarkable healthcare experience at reasonable costs.

For more information about DND International Eye Hospital, please contact:

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam

DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam

FREMONT, Calif., Dec. 6, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce its commercial presence in the Asia Pacific (APAC) region with the installation of the ARGOâ„¢ HT System, an advanced ultra-sensitive proteomics platform, at the prestigious Hong Kong Center for Neurodegenerative Diseases (HKCeND). The ARGO HT System along with the NULISAâ„¢ Platform are designed to revolutionize biomarker discovery by enabling researchers to detect and quantify proteins at unprecedented levels of sensitivity and accuracy.

"Expansion of the ARGO HT installed base to the APAC region represents a significant step forward in our vision to bring transformative proteomics solutions to researchers worldwide," said Dr. Yuling Luo, Founder, Chairman and CEO of Alamar Biosciences. "We are excited to contribute to HKCeND's vibrant scientific community and support groundbreaking advancements in the fight against neurodegenerative diseases."

Prof. Nancy Ip, the Director of Hong Kong Center for Neurodegenerative Diseases (HKCeND), added, "The integration of the NULISA Technology enabled by the ARGO HT System into our research infrastructure is a game-changer. This technology will allow us to explore the proteomic underpinnings of neurodegenerative diseases in ways that were previously unimaginable."

The partnership with HKCeND will focus on unlocking new insights into the molecular mechanisms of neurodegenerative diseases such as Alzheimer's disease, and Parkinson's disease. The ARGO HT System and NULISA Platform deployments will empower HKCeND's researchers to identify novel biomarkers, accelerate drug development, and improve early detection and personalized treatment strategies for patients.

About Alamar Biosciences, Inc.

Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company's proprietary NULISA Platform along with the ARGO HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit alamarbio.com.

About Hong Kong Center for Neurodegenerative Diseases
The Hong Kong Center for Neurodegenerative Diseases (HKCeND) is a leading research institution dedicated to advancing the understanding and treatment of neurodegenerative disorders. By fostering interdisciplinary collaborations and leveraging state-of-the-art technologies, HKCeND aims to make transformative contributions to global neuroscience.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases

Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases

Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases

Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases

Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases

Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases

Recommended Articles